COMMUNIQUÉS West-GlobeNewswire

Portola Pharmaceuticals to Present New Interim Phase 2 Data for Cerdulatinib at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
25/04/2018
– Novel Oral SYK/JAK Inhibitor for Relapsed/Refractory B-cell and T-cell Cancers – SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that new [...]
Decisions of the Annual General Meeting of Biohit Oyj
25/04/2018
Biohit Oyj Decisions of the Annual General Meeting April 25, 2018 at 8:00 pm local time (EEST) The Annual General Meeting (AGM) of Biohit Oyj held on Wednesday April 25, 2018 adopted the financial statements of the [...]
Aixplorer Mach 30 SuperSonic Imagine Pushes the Boundaries of Ultrasound Imaging
25/04/2018
With its sleek, functional design, new user experience and greater simplicity, the new SuperSonic Imagine’s ultrasound platform integrates the unique technological innovations such as the SonicPad and increased [...]
Stealth Mark Collaborates with Oak Ridge National Labs on Next Generation Authentication
25/04/2018
HOFFMAN ESTATES, IL , April 25, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc.’s (OTCQB: WCUI ) wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, is pleased to announce that they have concluded licensing [...]
Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
25/04/2018
Company to Host Investor Event on June 3, 2018 MORRIS PLAINS, N.J., April 25, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”), a leader in the field of antibody-drug [...]
Genmab Announces Data to be Presented at 2018 ASCO Annual Meeting
25/04/2018
Media Release 11 industry sponsored abstracts regarding Genmab programs scheduled for presentation at ASCO Annual Meeting One oral presentation, three poster discussion sessions and seven poster presentations Copenhagen [...]
BioSyent to Present at Upcoming Investor Conferences
25/04/2018
TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) is pleased to announce that it will be presenting at the following upcoming investor conferences: May 2, 2018 - Bloom Burton & [...]
CV Sciences, Inc. Fully Retires Convertible Debt
25/04/2018
Company Fully Repays Outstanding Convertible Debt and Avoids Dilution to Stockholders LAS VEGAS, April 25, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company,” “CV Sciences,” “our” or “we”) announced [...]
Tauriga Sciences Inc. to Present at European Institutional Investor Conference on June 21, 2018 in Berlin, Germany; Venue is the Representative Office of Baden-Wurttemberg in Berlin
25/04/2018
NEW YORK, NY, April 25, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]
Tauriga Sciences Inc. Board of Directors Approves 1 for 75 Reverse Split, Reducing Its Outstanding Common Stock to Approximately 52,300,000 Shares With a Proportional Reduction of Its Authorized Common Stock to 100,000,000 Shares
25/04/2018
NEW YORK, NY, April 25, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]
Scythian Biosciences Corp. Announces the Appointment of European Cannabis Leader Rob Reid of Prohibition Partners as CEO
25/04/2018
– In addition Scythian announces Liberty Health Sciences CEO George Scorsis as Chairman of the Board and Welcomes Back Rogers Communications Executive Roger Rai to the Board TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- [...]
Progyny and RESOLVE to Ring the Nasdaq Stock Market Closing Bell in Recognition of National Infertility Awareness Week®
25/04/2018
New York City, April 25, 2018 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, and RESOLVE: The National Infertility Association announced today they will ring the Nasdaq Stock Market [...]
Teladoc Announces U.S. Launch of Behavioral Health Navigator
25/04/2018
First Comprehensive Suite of Telebehavioral Health Services Improves Accuracy, Care Coordination and Access, to Drive Improved Outcomes PURCHASE, NY, April 25, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the [...]
Cesca Therapeutics Inc. to Exhibit at Several Upcoming Cell Therapy Conferences
25/04/2018
RANCHO CORDOVA, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: KOOL ) today announced that the Company will be exhibiting its full suite of cellular processing [...]
Sientra to Showcase OPUS™ Breast Products and miraDry fresh™ Procedure at American Society of Aesthetic Plastic Surgeons Meeting
25/04/2018
Unveils Sientra Platinum20™ Best in Class Warranty Program for OPUS Breast Implants Announces Preliminary Unaudited First Quarter 2018 Net Sales of Approximately $14.5 Million SANTA BARBARA, Calif., April 25, 2018 ( [...]
Profound Medical to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference
25/04/2018
TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Ascendis Pharma A/S Announces Upcoming Investor Presentations
25/04/2018
COPENHAGEN, Denmark, April 25, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a clinical stage biopharmaceutical company that applies its innovative TransCon technology to address significant unmet [...]
Alder BioPharmaceuticals® New Data Demonstrated Eptinezumab Increased Migraine-Free Intervals (Up to 32.5 days) and Improved Quality-of-Life Outcomes in Patients with Episodic Migraine
25/04/2018
Patients with a 75% or greater response experienced an eight-fold increase in migraine-free days and more meaningful improvements in bodily pain and physical function BOTHELL, Wash., April 25, 2018 (GLOBE NEWSWIRE) -- [...]
Targovax ASA: Issuance of restricted stock units (RSUs) to the board members
25/04/2018
Reference is made to the annual general meeting of Targovax ASA (the "Company") on 11 April 2018 (the "AGM") where election of members to the board of directors was according to the nomination committee's proposal. At [...]

Pages